A tissue-engineered biocomplex for periodontal reconstruction
Commonly referred to as the Wolverine Stack or Wolverine Blend across the research community, this combination allows researchers to investigate both compounds simultaneously in a single controlled preparation
Mechanism of Action: Triple Receptor Agonist Retatrutide is a synthetic peptide that activates three key metabolic receptors: GLP-1 (Glucagon-Like Peptide-1) Enhances insulin secretion, suppresses appetite, delays gastric emptying GIP (Glucose-Dependent Insulinotropic Polypeptide) Boosts insulin response, improves insulin sensitivity, may support lipid metabolism Glucagon Receptor (GCGR) Elevates energy expenditure, promotes fat oxidation, and may reduce liver fat This triple agonist profile delivers synergistic effects on glycemic control, fat loss, and metabolic health, making Retatrutide the most advanced incretin-based peptide in development
Limited Availability: Banned for use in supplements by the FDA in the U.S
Research indicates the peptide may help restore bone marrow function, reduce liver damage, and improve overall recovery trajectory following doxorubicin and other senescence-inducing chemotherapy agents
